Response to: 'Standard dose of ustekinumab for childhood-onset deficiency of interleukin-36 receptor antagonist' by Cherqaoui et al

Nadia Bonekamp, Roberta Caorsi, Joost Frenkel, Marco Gattorno

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)e89
JournalAnnals of the Rheumatic Diseases
Volume77
Issue number12
DOIs
Publication statusPublished - Dec 2018

Cite this

Response to: 'Standard dose of ustekinumab for childhood-onset deficiency of interleukin-36 receptor antagonist' by Cherqaoui et al. / Bonekamp, Nadia; Caorsi, Roberta; Frenkel, Joost; Gattorno, Marco.

In: Annals of the Rheumatic Diseases, Vol. 77, No. 12, 12.2018, p. e89.

Research output: Contribution to journalArticle

@article{f958cbb628db46ffbc14a84ad7c170de,
title = "Response to: 'Standard dose of ustekinumab for childhood-onset deficiency of interleukin-36 receptor antagonist' by Cherqaoui et al",
author = "Nadia Bonekamp and Roberta Caorsi and Joost Frenkel and Marco Gattorno",
year = "2018",
month = "12",
doi = "10.1136/annrheumdis-2017-212832",
language = "English",
volume = "77",
pages = "e89",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "12",

}

TY - JOUR

T1 - Response to: 'Standard dose of ustekinumab for childhood-onset deficiency of interleukin-36 receptor antagonist' by Cherqaoui et al

AU - Bonekamp, Nadia

AU - Caorsi, Roberta

AU - Frenkel, Joost

AU - Gattorno, Marco

PY - 2018/12

Y1 - 2018/12

U2 - 10.1136/annrheumdis-2017-212832

DO - 10.1136/annrheumdis-2017-212832

M3 - Article

VL - 77

SP - e89

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 12

ER -